Sophia Genetics News and Activities

Sophia Genetics is a company listed under the stock ticker SOPH (CH).

View the org chart displaying its 18 main executives

Most searched biographies at Sophia Genetics

• Jurgi Camblong, Chief Executive Officer and Director (becomes Exec...
• Vincent Ossipow, Independent Board Member
• Kathy Hibbs, Director

Popular executive movements at Sophia Genetics

• Ross Muken who is President, will be promoted to Chief Executive Officer on Jul. 1, 2026  (posted on January 14 2026).
• Jurgi Camblong who is Chief Executive Officer and Director, will become Executive Chairman on Jul. 1, 2026  (posted on January 14 2026).

Create your alert
to follow the executive moves at Sophia Genetics.

Sophia Genetics has 3,499 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Sophia Genetics

• SOPHiA GENETICS and ARC Regulatory Collaborate to Support EU Clinical Trial Assay Development
• Synnovis and SOPHiA GENETICS Collaborate to Bring Blood-based Cancer Testing to Patients Across the U.K.
• Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
• SOPHiA GENETICS Reports First Quarter 2026 Results
• SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
• Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
• SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results 
• SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
• AZ Delta Roeselare Joins the SOPHiA GENETICS Community
• CHU de Liège Advances Precision Oncology with SOPHiA GENETICS
• View more press releases Close

Social media about Sophia Genetics

• Sophia Genetics on Wikipedia, Google News & Yahoo Finance
• Sophia Genetics on LinkedIn, X (Twitter) & YouTube